Intercell vaccine gets U.S. paediatric approval
VIENNA May 21 (Reuters) - Austria's Intercell said on Tuesday it has won U.S. regulatory approval for paediatric use of its Ixiaro vaccine to protect against Japanese Encephalitis (JE), a step it had achieved in Europe in February.
"For the first time in nearly two years, a licensed vaccine will now be available to vaccinate traveling children and children of forward-deployed military personal in Asia as well against JE," Chief Executive Thomas Lingelbach said in a statement, calling the step a key growth element for the product.
- Seven NATO allies to create new rapid reaction force-report
- Ukraine seeks to join NATO; defiant Putin compares Kiev to Nazis |
- U.S. authorities investigate suspected threat against Obama: reports
- Putin says Russia must strengthen its economic, military position in Arctic
- California passes 'yes-means-yes' campus sexual assault bill